Skip to main content
Maria Cabanillas, MD, Endocrinology, Houston, TX

MariaE.CabanillasMDFACE

Endocrinology Houston, TX

Thyroid

Physician

Dr. Cabanillas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Cabanillas' full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161

Education & Training

  • Baylor College of Medicine
    Baylor College of MedicineFellowship, Endocrinology, Diabetes, and Metabolism, 2007 - 2009
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1998 - 2001
  • University of Puerto Rico School of Medicine
    University of Puerto Rico School of MedicineClass of 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • AZ State Medical License
    AZ State Medical License 2022 - 2026
  • GA State Medical License
    GA State Medical License 2023 - 2026
  • TN State Medical License
    TN State Medical License 2022 - 2026
  • TX State Medical License
    TX State Medical License 2001 - 2026
  • WA State Medical License
    WA State Medical License 2022 - 2026
  • AL State Medical License
    AL State Medical License 2023 - 2025
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Efficacy of Selpercatinib in RET-Altered Thyroid Cancers  
    Lori J Wirth, Jochen Lorch, Francis Worden, Marcia Brose, Taofeek K Owonikoko, Mark E Burkard, Todd M Bauer, Viola W Zhu, Nehal Lakhani, Victor Moreno, Manisha H Shah,..., The New England Journal of Medicine
  • Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine  
    Thinh Vu, Naifa L Busaidy, Maria E Cabanillas, Steven G Waguespack, Steven I Sherman, Mark Zafereo, The Journal of Clinical Endocrinology and Metabolism
  • Selective RET Kinase Inhibition for Patients with RET-Altered Cancers  
    L J Wirth, N L Busaidy, M E Cabanillas, Annals of Oncology

Lectures

  • New Medical Options for the Treatment of Advanced Thyroid Cancer 
    ENDO 2019 - New Orleans, LA - 3/24/2019
  • Advanced Thyroid Cancers: New Insights and Treatments 
    ENDO 2019 - New Orleans, LA - 3/25/2019
  • From Thyroid Nodules to Thyroid Cancer: Diagnosis and Treatment 
    ENDO 2019 - New Orleans, LA - 3/25/2019

Authored Content

  • Efficacy of Selpercatinib in RET-Altered Thyroid CancersAugust 2020

Press Mentions

  • Pembrolizumab Boosts Survival in Anaplastic Thyroid Cancer
    Pembrolizumab Boosts Survival in Anaplastic Thyroid CancerNovember 5th, 2024
  • Atezolizumab plus Targeted Agents Shows Promise in Anaplastic Thyroid Carcinoma
    Atezolizumab plus Targeted Agents Shows Promise in Anaplastic Thyroid CarcinomaOctober 28th, 2024
  • New Hope Against a Rare, Aggressive Form of Thyroid Cancer
    New Hope Against a Rare, Aggressive Form of Thyroid CancerOctober 28th, 2024
  • Join now to see all

Professional Memberships